Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluated the effect of perioperative parecoxib administration on postoperative pain, analgesic use, function recovery, inflammatory response and bleeding risk.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking Union Medical College Hospital
• Treatments: Parecoxib

Criteria

Inclusion Criteria:

1. Male or female patients who have underwent primary unilateral total knee arthroplasty (TKA) and total hip arthroplasty (THA).

2. Age between 18-65 years.

3. Chinese ethnicity.

Exclusion Criteria:

1. patients who underwent a reversion or a previous TKA or THA, emergency TKA, or TKA as result of a trauma.

2. patient exhibited allergy to parecoxib sodium.

3. lactating or pregnant.

4. any other conditions not suitable for surgery as evaluated by the surgeon in charge.